Skip to main content

Table 2 Patient characteristics of men diagnosed with non-metastatic prostate cancer stratified by the Cambridge Prognostic Group (CPG)

From: Risk stratification for prostate cancer management: value of the Cambridge Prognostic Group classification for assessing treatment allocation

 CPG1CPG2CPG3CPG4CPG5All men
No.%No.%No.%No.%No.%No.%
Age group (years)
 < 60263724.1262719.3105211.1155312.111187.4898714.5
 60–69496245.3590243.4345536.6514240.1488432.224,34539.3
 70–79303327.7452933.3427645.2531541.4682845.023,98138.7
 ≥ 803313.05303.96697.18216.4233515.446867.6
Number of comorbidities (RCS Charlson score)
 0869079.310,67278.5721676.310,00978.011,38375.147,97077.4
 1156514.3198514.6153116.2195315.2242716.0946115.3
 ≥ 27086.59316.97057.58696.813558.945687.4
Deprivation status (national quintiles)
 1 (least deprived)272024.8333824.6224323.7304823.8348223.014,83123.9
 2262023.9309322.8221823.5302823.6361323.814,57223.5
 3224920.5284721.0198621.0271521.2323121.313,02821.0
 4188117.2237817.5164717.4219817.1256416.910,66817.2
 5 (most deprived)149313.6193214.2135814.4184214.4227515.0890014.4
Ethnicity
 White944192.711,88792.5819891.611,26893.013,43794.054,23192.9
 Non-white7417.39677.57498.48497.08626.041687.1
 Missing781 734 505 714 866 3600